Laser capture microdissection: A new tool for the study of cerebral ischemia;Captura por microdisección láser: Una nueva herramienta para el estudio de la isquemia cerebral

Revista de Neurologia

Volumn 44, Issue 9, 2007, Pages 551-555

  Cuadrado, E ^a   Rosell, A ^a   Alvarez Sabin J ^a   Montaner, Joan ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cerebral ischemia; Gene expression; Ischemic cascade; Laser capture microdissection; Proteomics; Stroke

Indexed keywords

ASTROCYTE; BRAIN CELL; BRAIN ISCHEMIA; BRAIN TISSUE; CELL POPULATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; LASER CAPTURE MICRODISSECTION; MICROGLIA; MICROSCOPY; NERVE CELL NECROSIS; NEUROPROTECTION; OLIGODENDROGLIA; REPERFUSION; REVIEW; BRAIN; HISTOLOGY; INSTRUMENTATION; LASER; METHODOLOGY; MICRODISSECTION; PATHOLOGY; PATHOPHYSIOLOGY;

BRAIN; BRAIN ISCHEMIA; HUMANS; LASERS; MICRODISSECTION; MICROSCOPY;

EID: 34948904393     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4409.2006130     Document Type: Review

References (36)

1. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 24: 777-85.
2. Turley KR, Toledo-Pereyra LH, Kothari RU. Molelular mechanisms in the pathogenesis and treatment of acute ischemic stroke. J Invest Surg 2005; 18: 207-18.
3. Ovbiagle B, Kidwell C, Starkman S, Saver JL. Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 2003; 3: 9-30.
4. Chen SD, Lee JM, Yang DI, Nassief A, Hsu CY. Combination therapy for ischemic stroke: Potential of neuroprotectants plus thrombolytics. Am J Cardiovasc Drugs 2002; 5: 303-13.
5. Zukin RS, Jover T, Yokota H, Cappuccio I, Calderone A, Tanaka H, et al. Molecular and cellular mechanisms of ischemia-induced neuronal death. In Mohr JP, ed. Stroke: pathogenesis, diagnosis, and management. Philadelphia: Churchill Livingstone; 2004. p. 829-54.
6. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies KJ. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem 1990; 265: 16330-6.
7. Rego AC, Santos MS, Oliveira CR. Glutamate mediated inhibition of oxidative phosphorylation in cultured retinal cells. Neurochem Int 2000; 36: 159-66.
8. Murphy S, Simmons ML, Agullo L, García A, Feinstein DL, Galea E, et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 1993; 16: 323-8.
9. Merrill JE, Murphy SP, Mitrovic B, Mackenzie-Graham A, Dopp JC, Ding M, et al. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J Neuros Res 1997; 48: 372-84.
10. Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res 2004 26: 884-92.
11. Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strogin AY, et al. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in trasient focal cerebral ischemia. Neurobiol Dis 2005; 27: 6401-8.
12. Rosenberg GA, Navratil M, Barone F, Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996; 16: 360-6.
13. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2: 502-11.
14. Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Cic Physiol 2005; 289: 558-68.
15. Montaner J, Álvarez-Sabín J, Molina C, Anglés A, Abilleira S, Arenillas J, et al. Matrix metalloproteinase expression after human cardioembolic stroke. Temporal profile and relation to neurological impairment. Stroke 2001; 32: 1759-66.
16. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21: 7724-32.
17. Anthony DC, Ferguson B, Matyszak MK, Miller KM, Esiri MM, Perry VH. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 1997; 23: 406-15.
18. Nedergaard M, Dirnagl U. Role of glial cells in cerebral ischemia. Glia 2005; 50: 281-6.
19. Going JJ, Lamb RF. Practical histological microdissection for PCR analysis. J Pathol 1996; 179: 121-4.
20. Rubin MA. Understanding disease cell by cell. Science 2002; 296: 1329-30.
21. Shibata D, Hawes D, Li ZH, Hernández AM, Spruck CH, Nichols PW. Specific genetic analysis of microscopic tissue after selective ultraviolet radiation fractionation and the polymerase chain reaction. Am J Pathol 1992; 141: 539-43.
22. Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 1998; 14: 272-6.
23. Strausberg RL. The cancer genome anatomy project: new resources for reading the molecular signatures of cancer. J Pathol 2001; 195: 31-40.
24. Bonner RF, Emmert-Buck ME, Cole K, Pohida T, Chuaqui R, Goldstein S, et al. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278: 1481-3.
25. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RD, Zhuang Z, Goldstein SR, et al. Laser capture microdissection. Science 1996; 274: 998-1001.
26. Vincent VAM, De Voss JJ, Ryan HS, Murphy GM Jr. Analysis of neuronal gene expression with laser capture microdissection. J Neurosci Res 2002; 69: 578-86.
27. Moulédous L, Hunt S, Harcourt R, Harry J, Williams KL, Gutstein HB. Navigated laser capture microdissection as an alternative to direct histological staining for proteomic analysis of brain samples. Proteomics 2003; 3: 610-5.
28. Moulédous L, Hunt S, Harcourt R, Harry J, Williams KL, Gutstein HB. Proteomic analysis of immunostained, laser-capture microdissected brain samples. Electrophoresis 2003; 24: 296-302.
29. Kamme F, Salunga R, Yu J, Tran DT, Zhu J, Lou L, et al. Single-cell microarray analysis in hippocampus CA1: Demonstration and validation of cellular heterogeneity. J Neurosci 2003; 23: 3607-15.
30. Watanabe H, Tanaka F, Doyu M, Riku S, Yoshida M, Hashizume Y, et al. Differential somatic CAG repeat instability in variable brain cell lineage in dentatorubral pallidoluysian atrophy (DRPLA): a laser-captured microdissection (LCM)-based analysis. Hum Genet 2000; 107: 452-7.
31. Fassunke J, Majores M, Ullmann C, Elger CE, Schramm J, Wiestler OD, et al. In situ-RT and immunolaser microdissection for mRNA analysis of individual cells isolated from epilepsy-associated glioneuronal tumors. Lab Invest 2004; 54: 1520-5.
32. Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, et al. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res 2005; 136: 45-53.
33. Hellencourt CL, Harry GJ. Molecular profiles of mRNA levels in laser capture microdissected murine hippocampal regions differentially responsive to TMT-induced cell death. J Neurochem 2005; 93: 206-20.
34. Pérez-Manso M, Barroso-Chinea P, Aymerich MS, Lanciego JL. 'Functional' neuroanatomical tract tracing: analysis of changes in gene expression of brain circuits of interest. Brain Res 2006; 1072: 91-8.
35. Liu XS, Zhang ZG, Zhang L, Morris DC, Kapke A, Lu M, et al. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. J Cereb Blood Flow Metab 2006; 26: 787-96.
36. Haqqani AS, Nesic M, Preston E, Baumann E, Kelly J, Stanimirovic D. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 2005; 19: 1809-21.